Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesAngiotensin II up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor
The Prostate, 06/12/09
Bose SK et al. - Therefore, PAX2 may be a novel therapeutic target for the treatment of carcinomas such as prostate cancer via the down-regulation of its expression by targeting the AT1R signaling pathways.
Related Articles
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
Relevance Score: 72%
Prostate Cancer Specific Mortality and Gleason 7 Disease Differences in Prostate Cancer Outcomes Between Cases With Gleason 4 + 3 and Gleason 3 + 4 Tumors in a Population Based Cohort
The Journal of Urology, 11/20/09
Relevance Score: 71%
A prospective study of lifetime physical activity and prostate cancer incidence and mortality
British Journal of Cancer, 11/02/09
Relevance Score: 71%
Association of 17 prostate cancer susceptibility loci with prostate cancer risk in Chinese men
The Prostate, 11/02/09
Relevance Score: 71%
Prostate specific antigen for early detection of prostate cancer: longitudinal study
British Medical Journal, 10/08/09
Relevance Score: 71%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Promoter hypermethylation in tumour suppressor genes and response to interleukin-2 treatment in bladder cancer: a pilot study
Journal of Cancer Research & Clinical Oncology, 12/03/09
DNA repair gene polymorphisms and prostate cancer risk in South Australia--results of a pilot study
Urologic Oncology: Seminars and Original Investigations, 12/03/09
Evaluation of a modification of the UPOINT clinical phenotype system for the chronic pelvic pain syndrome
Scandinavian Journal of Urology and Nephrology, 12/03/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Current status of chemotherapy in risk-adapted management for metastatic testicular germ cell cancer
Cancer Science, 12/03/09
XPC gene variants: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy
Journal of Cancer Research & Clinical Oncology, 12/03/09
Promoter hypermethylation in tumour suppressor genes and response to interleukin-2 treatment in bladder cancer: a pilot study
Journal of Cancer Research & Clinical Oncology, 12/03/09
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Overexpression of RAD51 occurs in aggressive prostatic cancer
Histopathology, 12/03/09
A Risk-Based Strategy Improves Prostate-Specific AntigenDriven Detection of Prostate Cancer
European Urology, 12/03/09
DNA repair gene polymorphisms and prostate cancer risk in South Australia--results of a pilot study
Urologic Oncology: Seminars and Original Investigations, 12/03/09
Article Search
Sponsor